New Insulins, Biosimilars, and Insulin Therapy

Diabetes Technol Ther. 2021 Jun;23(S2):S46-S68. doi: 10.1089/dia.2021.2504.

Authors

Thomas Danne¹, Lutz Heinemann², Jan Bolinder³

Affiliations

¹ Diabetes-Zentrum für Kinder and Jugendliche, Kinder- und Jugendkrankenhaus AUF DER BULT, Hannover, Germany.
² Science Consulting in Diabetes GmbH, Neuss, Germany.
³ Department of Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.

PMID: 34061629
DOI: 10.1089/dia.2021.2504

No abstract available

MeSH terms

Biosimilar Pharmaceuticals* / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin, Regular, Human
Insulins* / therapeutic use

Substances

Biosimilar Pharmaceuticals
Hypoglycemic Agents
Insulin
Insulin, Regular, Human
Insulins